Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RK8U
|
|||
| Former ID |
DIB002489
|
|||
| Drug Name |
JKB-122
|
|||
| Synonyms |
Opioid receptor modulator (liver disease), Jenken Bioscience
Click to Show/Hide
|
|||
| Indication | Hepatitis virus infection [ICD-11: 1E50-1E51; ICD-9: 573.3] | Phase 2 | [1] | |
| Company |
Jenken Biosciences
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor (OPR) | Target Info | Modulator | [2], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02556372) Liver Test Study of Using JKB-122 in AIH Patients. | |||
| REF 2 | WO patent application no. 2011,1401,90, Tetrazolones as inhibitors of fatty acid synthase. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.